EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences

Locquet, M., Beaudart, C., Petermans, J., Reginster, J. Y., & Bruyère, O. (2019, March 1). EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. Journal of the American Medical Directors Association. Elsevier Inc. https://doi.org/10.1016/j.jamda.2018.11.027